News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
CRISPR 2.0, the Next Generation
June 21, 2024
Aspen Ideas: Health
CRISPR 2.0, the Next Generation
June 21, 2024
All Stories
News
Top Five Privately Held Gene Editing Therapy Companies
May 31, 2024
Genetic Engineering & Biotechnology News
Read Now
Press Release
Top Five Privately Held Gene Editing Therapy Companies
May 31, 2024
Genetic Engineering & Biotechnology News
Read Now
News
Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics
May 22, 2024
Ropes & Gray
Read Now
Press Release
Women @ RopesTalk: Conversation with Svetlana Lucas, Scribe Therapeutics
May 22, 2024
Ropes & Gray
Read Now
News
Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting
May 10, 2024
Read Now
Press Release
Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting
May 10, 2024
Read Now
News
DNA: Cutting the Future of Genome Editing
May 2, 2024
The Biomedical Scientist
Read Now
Press Release
DNA: Cutting the Future of Genome Editing
May 2, 2024
The Biomedical Scientist
Read Now
News
Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
Read Now
Press Release
Scribe Therapeutics to Present on Advances in CRISPR Genome and Epigenome Editing at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
Read Now